The Latest Breaking News from Praxis

Praxis said Tuesday every patient in a study responded to its experimental epilepsy treatment. The biotech stock rocketed to a year high.

From Delia to Nigella, and the River Cafe to the Pie Room, here are the best cookbooks to see you through Christmas

Speaking ahead of 75th Windrush anniversary, Fitzroy Maynard tells how he lost his home after being unable to prove he had the right to work

The Intel Core i7-13700K is a fantastic processor with outstanding performance across the board for an even better price, though its power efficiency leaves much to be desired.

Giant enters the lightweight e-MTB with their full-power Trance X Advanced E+ Elite and it's loaded with tech

‘This is no way to treat people who have made, and will continue to make, their lives in the UK’

Sally Daghlian OBE, Praxis CEO, says her charity for migrants and refugees sees the 'human cost' of the hostile environment created by the Conservative Party every single day

Praxis Precision Medicines Inc (NASDAQ:PRAX) announced topline results from Part B of its Phase 2a study evaluating the safety and efficacy of PRAX-944 for essential tremor (ET).  Treatment with PRAX-944 resulted in clinically meaningful improvements in function, supported by improvements in tremor amplitude. In the open-label period through Day 42, patients treated with…

‘Mothers we support are regularly pushed to jump through hoops, take on several jobs and sometimes, sadly, stay in abusive relationships in order to be able to feed and look after their children,’ says campaigner